NHS needs better plan around weight loss jabs, warn experts

An urgent examination is necessary to ensure that people in England can get weight loss such as Wegovy and Mounjaro on the NHS, warn the best experts.

This occurs one day after the Prime Minister said such injections could stimulate the British economy by making the unemployed obese “at work”.

More than 200 doctors and specialists have now written to the Secretary of Health to say how the obesity processing services of the stretched NHS are faced with unprecedented demand from patients who wish these drugs.

They warn that injections are only part of what should be a wider set of non -stigmatizing care.

They say that the government must solve certain fundamental problems in the obesity services of the NHS-chronic under-funding, challenges of labor and unequal access to care.

The letter to Wes Streting is sent by the Obesity Health Alliance (OHA), which represents health organizations in health and royal medical colleges, and has compiled a report.

He indicates that some patients can wait up to five years for specialized support, and that certain services are so extinguished that they have completely closed their waiting lists.

The OHA wants to see fair access for obesity treatments, including weight loss injections.

There have been reports of shortages of global actions and, currently in the United Kingdom on the NHS, the injections can only be offered through specialized weight management services.

Some patients become private, but many others are missing, warns the OHA.

According to the OHA, about four million people in England are eligible for Wegovy, but NHS projections estimate that in 2028, less than 50,000 people per year would obtain treatment.

Katharine Jenner, OHA director, said the weight loss blows were effective, but that was not the whole table.

“Even if you take the blows, you must always have additional care and support. You must always exercise and also have food advice and it is not currently there.

“There are also concerns about who has access to this drug. We must make sure that we favor access based on the biggest clinical needs and not on other factors.”

She added that the OHA had heard of people who had the right to access treatment services because of their excess weight.

“They have to request private treatment and do not get the care and support package they would expect to obtain if you had another kind of condition,” she said.

“We must have an examination of the existing NHS services to identify cases of very good good practices and identify the challenges that exist everywhere.”

The future approval of the NHS to use another injection, called Mounjaro, nicknamed by some like the King Kong of weight stroke for the way it seems that it works in the tests, should exert pressure even more pressure on the system, prevents the ratio.

Alfie Slade, government affairs leading the OHA, said: “New weight loss drugs represent a breakthrough in treatment, giving hope to the millions of people who find it difficult to manage their weight, but they also expose the weaknesses of our current obesity services.

“Without an intervention by the urgent government, we will not meet the needs of millions of patients, leading to greater health inequalities.”

Despite the advantages, health experts also warn that Wegovy and Mounjaro, who imitate a hormone that makes people less hungry, are not a quick solution. Patients should always exercise and look at what they eat.

Users can gain weight once they have stopped the medication.

And, as for any medication, there may be side effects.

Doctors are concerned about the growing number of patients they see with complications by taking weight loss drugs purchased online without clinical supervision.

In many cases, people may not get what they think is, which can be very dangerous.

Public health measures to help prevent obesity problems in the first place, such as improving the country’s diet and to help children do enough exercise, are also vital, explains the OHA.

The NHS England said that it was working with the government and the industry to develop new types of services which mean that approved treatments can be deployed safely, efficiently and at an affordable price.

A spokesperson said that weight loss drugs would be “transformers” and, alongside early NHS prevention initiatives, “help more people lose weight and reduce their risk of killer conditions such as diabetes, heart attack and stroke.”

A spokesperson for the Ministry of Health and Social Care said that obesity “costs NHS over 11 billion pounds sterling per year and that it also grants an important burden for our economy.”

“With an obesity-related disease, people take more days off, obesity drugs can be part of the solution,” they said.

The spokesperson also said that advertising restrictions on junk food and the ban on the sale of high caffeine energy drinks would help children attack the “obesity crisis”.